Medicine catalog

Search official names, active ingredients, and BDPM codes. Cards show a readable name and form; the exact French source details are available below.

Total in catalog: 20,854 · 24 shown

Commercialized according to BDPM

UPLIZNA 100 mg, concentrate for solution for infusion

Active ingredients: Inebilizumab

Original BDPM details in French

Official name: UPLIZNA 100 mg, solution à diluer pour perfusion
Active ingredients: INÉBILIZUMAB
Package description: 3 flacons en verre de 10 mL

CIS 60878038CIP7 5508914CIP13 3400955089148

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

AVTOZMA 162 mg, solution for injection in a pre-filled syringe

Active ingredients: Tocilizumab

Original BDPM details in French

Official name: AVTOZMA 162 mg, solution injectable en seringue préremplie
Active ingredients: TOCILIZUMAB
Package description: 1 seringue préremplie en verre de 0,9 mL

CIS 65554606CIP7 3030960CIP13 3400930309605

View details

Estimated price€245.30No current ANSM shortage notice is included

Commercialized according to BDPM

AVTOZMA 162 mg, solution for injection in a pre-filled pen

Active ingredients: Tocilizumab

Original BDPM details in French

Official name: AVTOZMA 162 mg, solution injectable en stylo prérempli
Active ingredients: TOCILIZUMAB
Package description: 1 seringue préremplie en verre dans stylo pré-rempli de 0,9 mL

CIS 65881305CIP7 3030963CIP13 3400930309636

View details

Estimated price€245.30No current ANSM shortage notice is included

Commercialized according to BDPM

AVTOZMA 20 mg/ml, concentrate for solution for infusion

Active ingredients: Tocilizumab

Original BDPM details in French

Official name: AVTOZMA 20 mg/mL, solution à diluer pour perfusion
Active ingredients: TOCILIZUMAB
Package description: 1 flacon en verre de 4 mL

CIS 60051070CIP7 5510608CIP13 3400955106081

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

AVTOZMA 20 mg/ml, concentrate for solution for infusion

Active ingredients: Tocilizumab

Original BDPM details in French

Official name: AVTOZMA 20 mg/mL, solution à diluer pour perfusion
Active ingredients: TOCILIZUMAB
Package description: 1 flacon en verre de 10 mL

CIS 60051070CIP7 5510610CIP13 3400955106104

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

AVTOZMA 20 mg/ml, concentrate for solution for infusion

Active ingredients: Tocilizumab

Original BDPM details in French

Official name: AVTOZMA 20 mg/mL, solution à diluer pour perfusion
Active ingredients: TOCILIZUMAB
Package description: 1 flacon en verre de 20 mL

CIS 60051070CIP7 5510612CIP13 3400955106128

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

ROACTEMRA 162 mg, solution for injection in a pre-filled syringe

Active ingredients: Tocilizumab

Original BDPM details in French

Official name: ROACTEMRA 162 mg, solution injectable en seringue préremplie
Active ingredients: TOCILIZUMAB
Package description: 4 seringue(s) préremplie(s) en verre de 0,9 ml

CIS 69107620CIP7 2782484CIP13 3400927824845

View details

Estimated price€1,146.80No current ANSM shortage notice is included

Commercialized according to BDPM

ROACTEMRA 162 mg, solution for injection in a pre-filled pen

Active ingredients: Tocilizumab

Original BDPM details in French

Official name: ROACTEMRA 162 mg, solution injectable en stylo prérempli
Active ingredients: TOCILIZUMAB
Package description: 4 stylos préremplis en verre de 0,9 ml

CIS 67121308CIP7 3014552CIP13 3400930145524

View details

Estimated price€1,146.80No current ANSM shortage notice is included

Commercialized according to BDPM

ROACTEMRA 20 mg/ml, concentrate for solution for infusion

Active ingredients: Tocilizumab

Original BDPM details in French

Official name: ROACTEMRA 20 mg/ml, solution à diluer pour perfusion
Active ingredients: TOCILIZUMAB
Package description: 1 flacon(s) en verre de 4 ml

CIS 69582503CIP7 5746431CIP13 3400957464318

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

ROACTEMRA 20 mg/ml, concentrate for solution for infusion

Active ingredients: Tocilizumab

Original BDPM details in French

Official name: ROACTEMRA 20 mg/ml, solution à diluer pour perfusion
Active ingredients: TOCILIZUMAB
Package description: 1 flacon(s) en verre de 10 ml

CIS 69582503CIP7 5746448CIP13 3400957464486

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

ROACTEMRA 20 mg/ml, concentrate for solution for infusion

Active ingredients: Tocilizumab

Original BDPM details in French

Official name: ROACTEMRA 20 mg/ml, solution à diluer pour perfusion
Active ingredients: TOCILIZUMAB
Package description: 1 flacon(s) en verre de 20 ml

CIS 69582503CIP7 5746454CIP13 3400957464547

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

TYENNE 162 mg, solution for injection in a pre-filled syringe

Active ingredients: Tocilizumab

Original BDPM details in French

Official name: TYENNE 162 mg, solution injectable en seringue préremplie
Active ingredients: TOCILIZUMAB
Package description: 4 seringues préremplies en verre de 0,9 mL

CIS 62118347CIP7 3027842CIP13 3400930278420

View details

Estimated price€966.04No current ANSM shortage notice is included

Commercialized according to BDPM

TYENNE 162 mg, solution for injection in a pre-filled pen

Active ingredients: Tocilizumab

Original BDPM details in French

Official name: TYENNE 162 mg, solution injectable en stylo prérempli
Active ingredients: TOCILIZUMAB
Package description: 4 stylos préremplis en verre de 0,9 mL

CIS 66297328CIP7 3027843CIP13 3400930278437

View details

Estimated price€966.04No current ANSM shortage notice is included

Commercialized according to BDPM

TYENNE 20 mg/ml, concentrate for solution for infusion

Active ingredients: Tocilizumab

Original BDPM details in French

Official name: TYENNE 20 mg/mL, solution à diluer pour perfusion
Active ingredients: TOCILIZUMAB
Package description: 1 flacon en verre de 4 mL

CIS 63322630CIP7 5509723CIP13 3400955097235

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

TYENNE 20 mg/ml, concentrate for solution for infusion

Active ingredients: Tocilizumab

Original BDPM details in French

Official name: TYENNE 20 mg/mL, solution à diluer pour perfusion
Active ingredients: TOCILIZUMAB
Package description: 1 flacon en verre de 10 mL

CIS 63322630CIP7 5509724CIP13 3400955097242

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

TYENNE 20 mg/ml, concentrate for solution for infusion

Active ingredients: Tocilizumab

Original BDPM details in French

Official name: TYENNE 20 mg/mL, solution à diluer pour perfusion
Active ingredients: TOCILIZUMAB
Package description: 1 flacon en verre de 20 mL

CIS 63322630CIP7 5509726CIP13 3400955097266

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

BEKEMV 300 mg, concentrate for solution for infusion

Active ingredients: Eculizumab

Original BDPM details in French

Official name: BEKEMV 300 mg, solution à diluer pour perfusion
Active ingredients: ÉCULIZUMAB
Package description: 1 flacon en verre de 30 mL

CIS 63275561CIP7 5509565CIP13 3400955095651

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

ENSPRYNG 120 mg, solution for injection in a pre-filled syringe

Active ingredients: Satralizumab

Original BDPM details in French

Official name: ENSPRYNG 120 mg, solution injectable en seringue préremplie
Active ingredients: SATRALIZUMAB
Package description: 1 seringue(s) préremplie(s) polymère de 1 ml

CIS 69326436CIP7 3023443CIP13 3400930234433

View details

Estimated price€15,122.68No current ANSM shortage notice is included

Commercialized according to BDPM

ENTYVIO 108 mg, solution for injection in a pre-filled syringe

Active ingredients: VÉDOLIZUMAB

Original BDPM details in French

Official name: ENTYVIO 108 mg, solution injectable en seringue préremplie
Active ingredients: VÉDOLIZUMAB
Package description: 2 seringue(s) préremplie(s) en verre de 0,68 ml (conditionnement multiple)

CIS 69607230CIP7 3020866CIP13 3400930208663

View details

Estimated price€1,129.46No current ANSM shortage notice is included

Commercialized according to BDPM

ENTYVIO 108 mg, solution for injection in a pre-filled pen

Active ingredients: VÉDOLIZUMAB

Original BDPM details in French

Official name: ENTYVIO 108 mg, solution injectable en stylo prérempli
Active ingredients: VÉDOLIZUMAB
Package description: 2 stylos préremplis en verre de 0,68 ml (conditionnement multiple)

CIS 67320648CIP7 3020868CIP13 3400930208687

View details

Estimated price€1,129.46No current ANSM shortage notice is included

Commercialized according to BDPM

ENTYVIO 300 mg, powder for concentrate for infusion

Active ingredients: VÉDOLIZUMAB

Original BDPM details in French

Official name: ENTYVIO 300 mg, poudre pour solution à diluer pour perfusion
Active ingredients: VÉDOLIZUMAB
Package description: 1 flacon(s) en verre

CIS 66320218CIP7 5867287CIP13 3400958672873

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

EPYSQLI 300 mg, concentrate for solution for infusion

Active ingredients: Eculizumab

Original BDPM details in French

Official name: EPYSQLI 300 mg, solution à diluer pour perfusion
Active ingredients: ÉCULIZUMAB
Package description: 1 flacon(s) en verre de 30 ml

CIS 67665594CIP7 5509624CIP13 3400955096245

View details

Estimated priceAsk the manager for the priceNo current ANSM shortage notice is included

Commercialized according to BDPM

FASENRA 30 mg, solution for injection in a pre-filled syringe

Active ingredients: Benralizumab

Original BDPM details in French

Official name: FASENRA 30 mg, solution injectable en seringue préremplie
Active ingredients: BENRALIZUMAB
Package description: 1 seringue préremplie en verre de 1 ml avec une aiguille et un protège -aiguille rigide et un bouchon-piston

CIS 63562134CIP7 3013294CIP13 3400930132944

View details

Estimated price€3,994.88No current ANSM shortage notice is included

Commercialized according to BDPM

FASENRA 30 mg, solution for injection in a pre-filled pen

Active ingredients: Benralizumab

Original BDPM details in French

Official name: FASENRA 30 mg, solution injectable en stylo prérempli
Active ingredients: BENRALIZUMAB
Package description: 1 stylo prérempli en verre de 1 ml avec une aiguille et un protège -aiguille rigide et un bouchon-piston

CIS 63094493CIP7 3018783CIP13 3400930187838

View details

Estimated price€3,994.88No current ANSM shortage notice is included

The displayed price is an estimate. It is not an offer to sell or confirmation of stock. Current catalog version published 4 Nov 2026.